MedTrace Logo

Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization.

NCT07303335 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-12-24

No results posted yet for this study

Summary

This is a prospective, observational study at the ICU of Hospital Mútua de Terrassa, running from May to December 2025. The primary goal is to determine the prevalence of sarcopenia in adult patients requiring more than 48 hours of mechanical ventilation. Sarcopenia is assessed using the SARC-F score, impedanciometry, and quadriceps ultrasound. Secondary aims include tracking the development of ICU-Acquired Weakness (ICU-AW) using the MRC score. All data is collected anonymously after obtaining informed consent.

Conditions

  • Sarcopenia
  • Critical Illness
  • Intensive Care (ICU) Myopathy
  • Body Composition Measurement
  • Bio-Impedance Measurements
  • Ultrasound Evaluation

Sponsors & Collaborators

  • Hospital Mutua de Terrassa

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-14
Primary Completion
2025-12-31
Completion
2026-02-28

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07303335 on ClinicalTrials.gov